Next 10 |
home / stock / cve / cve articles
Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years by 3.79% on an annualized basis producing an average annual return of 1...
Cenovus Energy Inc. (NYSE:CVE) is reportedly making an investment of $1.5 billion in its Ohio refineries, including Lima and Oregon. The compa...
In a significant development in the energy sector, Iraq is set to reactivate a previously dormant pipeline to Turkey, which could substantially imp...
Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years by 3.81% on an annualized basis producing an average annual return of 1...
U.S. stock futures were higher this morning, with the Dow futures gaining by more than 100 points on Wednesday. Shares of GameStop Corp. (NYSE: G...
CALGARY, Alberta, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) will hold its 2024 Investor Day in Toronto on Tuesd...
Nuclear fusion reached a new milestone, generating more energy than ever before during an experiment conducted at the Joint European Torus (JET) la...
Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years by 2.72% on an annualized basis producing an average annual return of 1...
Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years by 4.91% on an annualized basis producing an average annual return of 1...
News, Short Squeeze, Breakout and More Instantly...
Pegasystems Inc. (PEGA) is expected to report $0.2 for Q1 2024 Masco Corporation (MAS) is expected to report $0.87 for Q1 2024 Avery Dennison Corporation (AVY) is expected to report $2.15 for Q1 2024 Vista Energy S.A.B. de C.V. American Depositary Shares each representing one series A...
Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years by 3.79% on an annualized basis producing an average annual return of 1...
2024-04-19 14:30:04 ET National Bank analyst issues OUTPERFORM recommendation for CVE on April 19, 2024 01:02PM ET. The previous analyst recommendation was Outperform. CVE was trading at $21 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...